Vor bio to participate in the oppenheimer's 35th annual healthcare life sciences conference

Cambridge, mass., feb. 03, 2025 (globe newswire) -- vor bio (nasdaq: vor), a clinical-stage cell and genome engineering company, today announced that it will participate in a fireside chat and host virtual 1x1 investor meetings at the oppenheimer's 35th annual healthcare life sciences conference.
VOR Ratings Summary
VOR Quant Ranking